Tamiflu-resistant but HA-mediated cell-to-cell transmission through apical membranes of cell-associated influenza viruses

PLoS ONE

Volumn 6, Issue 11, 2011, Pages

  Mori, Kotaro ^a   Haruyama, Takahiro ^a,b   Nagata, Kyosuke ^a  

^a UNIVERSITY OF TSUKUBA   (Japan)

^b AVSS CORPORATION   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

AMANTADINE; GREEN FLUORESCENT PROTEIN; INFLUENZA VIRUS HEMAGGLUTININ; NEUTRALIZING ANTIBODY; OSELTAMIVIR; SIALIDASE; VIRUS RNA;

ACIDIFICATION; AMINO ACID SUBSTITUTION; ANIMAL CELL; ANTIVIRAL RESISTANCE; APICAL MEMBRANE; ARTICLE; CELL COMMUNICATION; CELL DENSITY; CELL SURFACE; CONTROLLED STUDY; ENDOSOME; ENZYME ACTIVE SITE; ENZYME ACTIVITY; INFLUENZA VIRUS A; MOLECULAR IMAGING; NONHUMAN; PROGENY; PROTEIN LOCALIZATION; SIALIDASE GENE; VIRION; VIRUS CELL INTERACTION; VIRUS GENE; VIRUS GENOME; VIRUS INHIBITION; VIRUS PARTICLE; VIRUS RELEASE; VIRUS TRANSMISSION; VIRUS UNCOATING; WILD TYPE;

ANIMALS; ANTIBODIES, NEUTRALIZING; BASE SEQUENCE; CELL LINE; CELL MEMBRANE; CELL POLARITY; DOGS; DRUG RESISTANCE, VIRAL; HEK293 CELLS; HEMAGGLUTININ GLYCOPROTEINS, INFLUENZA VIRUS; HUMANS; INFLUENZA, HUMAN; MOLECULAR SEQUENCE DATA; MOVEMENT; NEURAMINIDASE; ORTHOMYXOVIRIDAE; ORTHOMYXOVIRIDAE INFECTIONS; OSELTAMIVIR;

EID: 82355161905     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0028178     Document Type: Article

References (54)

1. Sattentau Q, (2008) Avoiding the void: cell-to-cell spread of human viruses. Nat Rev Microbiol 6: 815-826.
2. Mothes W, Sherer NM, Jin J, Zhong P, (2010) Virus Cell-to-Cell Transmission. J Virol 84: 8360-8368.
3. Doceul V, Hollinshead M, van der Linden L, Smith GL, (2010) Repulsion of superinfecting virions: a mechanism for rapid virus spread. Science 327: 873-876.
4. Igakura T, Stinchcombe JC, Goon PK, Taylor GP, Weber JN, et al. (2003) Spread of HTLV-I between lymphocytes by virus-induced polarization of the cytoskeleton. Science 299: 1713-1716.
5. Dustin M, (2003) Viral spread through protoplasmic kiss. Nat Cell Biol 5: 271-272.
6. Hübner W, McNerney GP, Chen P, Dale BM, Gordon RE, et al. (2009) Quantitative 3D video microscopy of HIV transfer across T cell virological synapses. Science 323: 1743-1747.
7. Pais-Correia AM, Sachse M, Guadagnini S, Robbiati V, Lasserre R, et al. (2010) Biofilm-like extracellular viral assemblies mediate HTLV-1 cell-to-cell transmission at virological synapses. Nat Med 16: 83-89.
8. Evans MJ, von Hahn T, Tscherne DM, Syder AJ, Panis M, et al. (2007) Claudin-1 is a hepatitis C virus co-receptor required for a late step in entry. Nature 446: 801-805.
9. Ploss A, Evans MJ, Gaysinskaya VA, Panis M, You H, et al. (2009) Human occludin is a hepatitis C virus entry factor required for infection of mouse cells. Nature 457: 882-886.
10. Barton ES, Forrest JC, Connolly JL, Chappell JD, Liu Y, et al. (2001) Junction adhesion molecule is a receptor for reovirus. Cell 104: 441-451.
11. Balfe P, McKeating JA, (2009) The complexities of hepatitis C virus entry. J Hepatol 51: 609-611.
12. Wiley DC, Skehel JJ, (1987) The structure and function of the hemagglutinin membrane glycoprotein of influenza virus. Annu Rev Biochem 56: 365-394.
13. Suzuki Y, Ito T, Suzuki T, Holland RE, Chambers TM, et al. (2000) Sialic acid species as a determinant of the host range of influenza A viruses. J Virol 74: 11825-11831.
14. Skehel JJ, Bayley PM, Brown EB, Martin SR, Waterfield MD, et al. (1982) Changes in the conformation of influenza virus hemagglutinin at the pH optimum of virus-mediatedmozawa T, membrane fusion. P Natl Acad Sci Usa 79: 968-972.
15. Skehel JJ, Waterfield MD, (1975) Studies on the primary structure of the influenza virus hemagglutinin. P Natl Acad Sci Usa 72: 93-97.
16. Sato M, Yoshida S, Iida K, Tomozawa T, Kido H, et al. (2003) A novel influenza A virus activating enzyme from porcine lung: purification and characterization. Biol Chem 384: 219-227.
17. Lazarowitz SG, Choppin PW, (1975) Enhancement of the infectivity of influenza A and B viruses by proteolytic cleavage of the hemagglutinin polypeptide. Virology 68: 440-454.
18. Klenk HD, Rott R, Orlich M, Blödorn J, (1975) Activation of influenza A viruses by trypsin treatment. Virology 68: 426-439.
19. Kido H, Yokogoshi Y, Sakai K, Tashiro M, Kishino Y, et al. (1992) Isolation and characterization of a novel trypsin-like protease found in rat bronchiolar epithelial Clara cells. A possible activator of the viral fusion glycoprotein. J Biol Chem 267: 13573-13579.
20. Bullough PA, Hughson FM, Skehel JJ, Wiley DC, (1994) Structure of influenza haemagglutinin at the pH of membrane fusion. Nature 371: 37-43.
21. Tamm LK, Han X, Li Y, Lai AL, (2002) Structure and function of membrane fusion peptides. Biopolymers 66: 249-260.
22. Air GM, Laver WG, (1989) The neuraminidase of influenza virus. Proteins 6: 341-356.
23. Huang IC, Li W, Sui J, Marasco W, Choe H, et al. (2008) Influenza A virus neuraminidase limits viral superinfection. J Virol 82: 4834-4843.
24. Palese P, Tobita K, Ueda M, Compans RW, (1974) Characterization of temperature sensitive influenza virus mutants defective in neuraminidase. Virology 61: 397-410.
25. Shibata S, Yamamoto-Goshima F, Maeno K, Hanaichi T, Fujita Y, et al. (1993) Characterization of a temperature-sensitive influenza B virus mutant defective in neuraminidase. J Virol 67: 3264-3273.
26. Gubareva LV, Nedyalkova MS, Novikov DV, Murti KG, Hoffmann E, et al. (2002) A release-competent influenza A virus mutant lacking the coding capacity for the neuraminidase active site. J Gen Virol 83: 2683-2692.
27. Nedyalkova MS, Hayden FG, Webster RG, Gubareva LV, (2002) Accumulation of defective neuraminidase (NA) genes by influenza A viruses in the presence of NA inhibitors as a marker of reduced dependence on NA. J Infect Dis 185: 591-598.
28. Lew W, Chen X, Kim CU, (2000) Discovery and development of GS 4104 (oseltamivir): an orally active influenza neuraminidase inhibitor. Curr Med Chem 7: 663-672.
29. Fujii Y, Goto H, Watanabe T, Yoshida T, Kawaoka Y, (2003) Selective incorporation of influenza virus RNA segments into virions. P Natl Acad Sci Usa 100: 2002-2007.
30. Shinya K, Fujii Y, Ito H, Ito T, Kawaoka Y, (2004) Characterization of a neuraminidase-deficient influenza a virus as a potential gene delivery vector and a live vaccine. J Virol 78: 3083-3088.
31. Timpe JM, Stamataki Z, Jennings A, Hu K, Farquhar MJ, et al. (2008) Hepatitis C virus cell-cell transmission in hepatoma cells in the presence of neutralizing antibodies. Hepatology 47: 17-24.
32. Gupta P, Balachandran R, Ho M, Enrico A, Rinaldo C, (1989) Cell-to-cell transmission of human immunodeficiency virus type 1 in the presence of azidothymidine and neutralizing antibody. J Virol 63: 2361-2365.
33. Pinto LH, Holsinger LJ, Lamb RA, (1992) Influenza virus M2 protein has ion channel activity. Cell 69: 517-528.
34. Davies WL, Grunert RR, Haff RF, McGahen JW, Neumayer EM, et al. (1964) Antiviral Activity of 1-Adamantanamine (Amantadine). Science 144: 862-863.
35. Takeda M, Pekosz A, Shuck K, Pinto LH, Lamb RA, (2002) Influenza a virus M2 ion channel activity is essential for efficient replication in tissue culture. J Virol 76: 1391-1399.
36. Chodosh J, Gan Y, Holder VP, Sixbey JW, (2000) Patterned entry and egress by Epstein-Barr virus in polarized CR2-positive epithelial cells. Virology 266: 387-396.
37. Fuller S, von Bonsdorff CH, Simons K, (1984) Vesicular stomatitis virus infects and matures only through the basolateral surface of the polarized epithelial cell line, MDCK. Cell 38: 65-77.
38. Schlie K, Maisa A, Freiberg F, Groseth A, Strecker T, et al. (2010) Viral protein determinants of Lassa virus entry and release from polarized epithelial cells. J Virol 84: 3178-3188.
39. Blau DM, Compans RW, (1995) Entry and release of measles virus are polarized in epithelial cells. Virology 210: 91-99.
40. Brock SC, Goldenring JR, Crowe JE Jr, (2003) Apical recycling systems regulate directional budding of respiratory syncytial virus from polarized epithelial cells. Proc Natl Acad Sci U S A 100: 15143-15148.
41. Roberts SR, Compans RW, Wertz GW, (1995) Respiratory syncytial virus matures at the apical surfaces of polarized epithelial cells. J Virol 69: 2667-2673.
42. Tseng CT, Tseng J, Perrone L, Worthy M, Popov V, et al. (2005) Apical entry and release of severe acute respiratory syndrome-associated coronavirus in polarized Calu-3 lung epithelial cells. J Virol 79: 9470-9479.
43. Nayak DP, Hui EK, Barman S, (2004) Assembly and budding of influenza virus. Virus Research 106: 147-165.
44. Carrasco M, Amorim MJ, Digard P, (2004) Lipid raft-dependent targeting of the influenza A virus nucleoprotein to the apical plasma membrane. Traffic 5: 979-992.
45. Cresawn KO, Potter BA, Oztan A, Guerriero CJ, Ihrke G, et al. (2007) Differential involvement of endocytic compartments in the biosynthetic traffic of apical proteins. Embo J 26: 3737-3748.
46. Guerriero CJ, Lai Y, Weisz OA, (2008) Differential sorting and Golgi export requirements for raft-associated and raft-independent apical proteins along the biosynthetic pathway. J Biol Chem 283: 18040-18047.
47. Kawaguchi A, Naito T, Nagata K, (2005) Involvement of influenza virus PA subunit in assembly of functional RNA polymerase complexes. J Virol 79: 732-744.
48. Sugiura A, Ueda M, Tobita K, Enomoto C, (1975) Further isolation and characterization of temperature-sensitive mutants of influenza virus. Virology 65: 363-373.
49. Guyader M, Kiyokawa E, Abrami L, Turelli P, Trono D, (2002) Role for human immunodeficiency virus type 1 membrane cholesterol in viral internalization. J Virol 76: 10356-10364.
50. Jolly C, Sattentau QJ, (2005) Human immunodeficiency virus type 1 virological synapse formation in T cells requires lipid raft integrity. J Virol 79: 12088-12094.
51. Phillips DM, (1994) The role of cell-to-cell transmission in HIV infection. AIDS 8: 719-731.
52. Sato H, Orenstein J, Dimitrov D, Martin M, (1992) Cell-to-cell spread of HIV-1 occurs within minutes and may not involve the participation of virus particles. Virology 186: 712-724.
53. Kawaguchi A, Momose F, Nagata K, (2011) Replication-coupled and host factor-mediated encapsidation of the influenza virus genome by viral nucleoprotein. J Virol 85: 6197-6204.
54. Watanabe K, Handa H, Mizumoto K, Nagata K, (1996) Mechanism for inhibition of influenza virus RNA polymerase activity by matrix protein. J Virol 70: 241-247.